This research peptide blend combines three regenerative peptides into a single vial for studies examining complementary tissue repair pathways. GHK-Cu up-regulates wound healing processes and drives collagen production, elastin, and angiogenic growth-factor expression in laboratory models. BPC-157 exhibits gastro-protective, soft-tissue repair, and anti-inflammatory actions through nitric-oxide signaling, growth-factor receptor modulation, and cytokine balance. TB-500 (Thymosin Beta-4 Fragment) enhances cell migration and angiogenesis via actin-sequestering and integrin-linked pathways. Researchers can examine potential synergy across copper-mediated extracellular-matrix activation (GHK-Cu), cytoprotective signaling (BPC-157), and actin-dependent cell motility (TB-500). In vitro and ex vivo models evaluate collagen deposition rates, angiogenic indices, and recovery metrics following controlled tissue injury. Composition: 70 mg lyophilized blend per vial 50 mg GHK-Cu | 10 mg BPC-157 | 10 mg TB-500 Lyophilized Peptides All three peptides are supplied in a freeze-dried, filler-free state to maximize stability and preserve chemical integrity during refrigerated or frozen storage. Reconstitute with sterile solvent immediately prior to experimental use and store aliquots at ≤ –20 °C to prevent repeated freeze–thaw cycles.